| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Knockout Mice




From the Departments of Pathology,* Pharmacology,
Medicine,
and Medical Biostatistics,
University of Vermont, Burlington, Vermont; the Pediatric Pulmonary Division,|| Childrens Hospital of Pittsburgh, Pittsburgh, Pennsylvania; and the Department of Molecular Genetics,¶ Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
The signaling pathways leading to the development of asbestos-associated diseases are poorly understood. Here we used normal and protein kinase C (PKC)-
knockout (PKC
/) mice to demonstrate multiple roles of PKC-
in the development of cell proliferation and inflammation after inhalation of chrysotile asbestos. At 3 days, asbestos-induced peribronchiolar cell proliferation in wild-type mice was attenuated in PKC
/ mice. Cytokine profiles in bronchoalveolar lavage fluids showed increases in interleukin (IL)-1ß, IL-4, IL-6, and IL-13 that were decreased in PKC
/ mice. At 9 days, microarray and quantitative reverse transcriptase-polymerase chain reaction analysis of lung tissues revealed increased mRNA levels of the profibrotic cytokine, IL-4, in asbestos-exposed wild-type mice but not PKC
/ mice. PKC
/ mice also exhibited decreased lung infiltration of polymorphonuclear cells, natural killer cells, and macrophages in bronchoalveolar lavage fluid and lung, as well as increased numbers of B lymphocytes and plasma cells. These changes were accompanied by elevated mRNA levels of immunoglobulin chains. These data show that modulation of PKC-
has multiple effects on peribronchiolar cell proliferation, proinflammatory and profibrotic cytokine expression, and immune cell profiles in lung. These results also implicate targeted interruption of PKC-
as a potential therapeutic option in asbestos-induced lung diseases.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |